New drug nacresertib gets first safety check in healthy volunteers
NCT ID NCT07600762
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will test a single dose of the drug nacresertib in 12 healthy Japanese adults to see if it is safe and how the body processes it. The main goal is to check for side effects and measure drug levels in the blood. No treatment benefit is expected since participants are healthy volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel ACT- Anaheim Clinical Trials /ID# 282482
Anaheim, California, 92801, United States